Role of KCNMA1gene in breast cancer invasion and metastasis to brain
Open Access
- 29 July 2009
- journal article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 9 (1), 258
- https://doi.org/10.1186/1471-2407-9-258
Abstract
The prognosis for patients with breast tumor metastases to brain is extremely poor. Identification of prognostic molecular markers of the metastatic process is critical for designing therapeutic modalities for reducing the occurrence of metastasis. Although ubiquitously present in most human organs, large-conductance calcium- and voltage-activated potassium channel (BKCa) channels are significantly upregulated in breast cancer cells. In this study we investigated the role of KCNMA1 gene that encodes for the pore-forming α-subunit of BKCa channels in breast cancer metastasis and invasion. We performed Global exon array to study the expression of KCNMA1 in metastatic breast cancer to brain, compared its expression in primary breast cancer and breast cancers metastatic to other organs, and validated the findings by RT-PCR. Immunohistochemistry was performed to study the expression and localization of BKCa channel protein in primary and metastatic breast cancer tissues and breast cancer cell lines. We performed matrigel invasion, transendothelial migration and membrane potential assays in established lines of normal breast cells (MCF-10A), non-metastatic breast cancer (MCF-7), non-brain metastatic breast cancer cells (MDA-MB-231), and brain-specific metastatic breast cancer cells (MDA-MB-361) to study whether BKCa channel inhibition attenuates breast tumor invasion and metastasis using KCNMA1 knockdown with siRNA and biochemical inhibition with Iberiotoxin (IBTX). The Global exon array and RT-PCR showed higher KCNMA1 expression in metastatic breast cancer in brain compared to metastatic breast cancers in other organs. Our results clearly show that metastatic breast cancer cells exhibit increased BKCa channel activity, leading to greater invasiveness and transendothelial migration, both of which could be attenuated by blocking KCNMA1. Determining the relative abundance of BKCa channel expression in breast cancer metastatic to brain and the mechanism of its action in brain metastasis will provide a unique opportunity to identify and differentiate between low grade breast tumors that are at high risk for metastasis from those at low risk for metastasis. This distinction would in turn allow for the appropriate and efficient application of effective treatments while sparing patients with low risk for metastasis from the toxic side effects of chemotherapy.Keywords
This publication has 29 references indexed in Scilit:
- Silencing of hSlo potassium channels in human osteosarcoma cells promotes tumorigenesisInternational Journal of Cancer, 2008
- Human Brain Microvascular Endothelial Cells and Umbilical Vein Endothelial Cells Differentially Facilitate Leukocyte Recruitment and Utilize Chemokines for T Cell MigrationClinical and Developmental Immunology, 2008
- Ca2+‐activated K+ channels in human melanoma cells are up‐regulated by hypoxia involving hypoxia‐inducible factor‐1α and the von Hippel‐Lindau proteinThe Journal of Physiology, 2006
- Blood‐brain barrier‐specific properties of a human adult brain endothelial cell lineThe FASEB Journal, 2005
- Genes that mediate breast cancer metastasis to lungNature, 2005
- Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinomaCancer, 2003
- Enhancement of in vitro tumor—cell transcellular migration by tumor—cell—secreted endothelial—cell—retraction factorInternational Journal of Cancer, 1995
- Bradykinin Selectively Opens Blood-Tumor Barrier in Experimental Brain TumorsJournal of Cerebral Blood Flow & Metabolism, 1994
- Brain metastases in breast cancer; natural history, prognostic factors and outcomeJournal of Neuro-Oncology, 1993
- Increased leukotriene C4 and vasogenic edema surrounding brain tumors in humansAnnals of Neurology, 1986